George Warimwe
George Warimwe
確認したメール アドレス: ndm.ox.ac.uk
タイトル
引用先
引用先
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
10902021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
2052021
Targets of antibodies against Plasmodium falciparum–infected erythrocytes in malaria immunity
JA Chan, KB Howell, L Reiling, R Ataide, CL Mackintosh, FJI Fowkes, ...
The Journal of clinical investigation 122 (9), 3227-3238, 2012
2002012
Plasmodium falciparum var gene expression is modified by host immunity
GM Warimwe, TM Keane, G Fegan, JN Musyoki, CRJC Newton, A Pain, ...
Proceedings of the National Academy of Sciences 106 (51), 21801-21806, 2009
1522009
Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure
P Bejon, G Warimwe, CL Mackintosh, MJ Mackinnon, SM Kinyanjui, ...
Infection and immunity 77 (5), 1917-1923, 2009
1192009
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
NK Alharbi, E Padron-Regalado, CP Thompson, A Kupke, D Wells, ...
Vaccine 35 (30), 3780-3788, 2017
1082017
Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria
F Verra, J Simpore, GM Warimwe, KK Tetteh, T Howard, FHA Osier, ...
PloS one 2 (10), e978, 2007
1022007
Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy
V Naranbhai, AVS Hill, SS Abdool Karim, K Naidoo, Q Abdool Karim, ...
The Journal of infectious diseases 209 (4), 500-509, 2014
992014
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
S Uyoga, IMO Adetifa, HK Karanja, J Nyagwange, J Tuju, P Wanjiku, ...
Science 371 (6524), 79-82, 2021
882021
Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley fever
GM Warimwe, J Gesharisha, BV Carr, S Otieno, K Otingah, D Wright, ...
Scientific reports 6 (1), 1-7, 2016
782016
Prognostic indicators of life-threatening malaria are associated with distinct parasite variant antigen profiles
GM Warimwe, G Fegan, JN Musyoki, CRJC Newton, M Opiyo, G Githinji, ...
Science translational medicine 4 (129), 129ra45-129ra45, 2012
752012
The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children
GM Warimwe, LM Murungi, G Kamuyu, GM Nyangweso, J Wambua, ...
PLoS One 8 (2), e57320, 2013
562013
Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
VJ Munster, D Wells, T Lambe, D Wright, RJ Fischer, T Bushmaker, ...
npj Vaccines 2 (1), 1-4, 2017
522017
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice
GM Warimwe, G Lorenzo, E Lopez-Gil, A Reyes-Sandoval, ...
Virology journal 10 (1), 1-9, 2013
452013
In Vitro Inhibition of Plasmodium falciparum Rosette Formation by Curdlan Sulfate
HM Kyriacou, KE Steen, A Raza, M Arman, G Warimwe, PC Bull, I Havlik, ...
Antimicrobial agents and chemotherapy 51 (4), 1321-1326, 2007
452007
Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS, S malaria vaccine: analysis of pooled phase II clinical trial data
GM Warimwe, HA Fletcher, A Olotu, ST Agnandji, AVS Hill, K Marsh, ...
BMC medicine 11 (1), 1-6, 2013
382013
Systematic literature review of Rift Valley fever virus seroprevalence in livestock, wildlife and humans in Africa from 1968 to 2016
MHA Clark, GM Warimwe, A Di Nardo, NA Lyons, S Gubbins
PLoS neglected tropical diseases 12 (7), e0006627, 2018
372018
Global selection of Plasmodium falciparum virulence antigen expression by host antibodies
AI Abdi, GM Warimwe, MK Muthui, CA Kivisi, EW Kiragu, GW Fegan, ...
Scientific reports 6 (1), 1-9, 2016
302016
A protective monoclonal antibody targets a site of vulnerability on the surface of Rift Valley fever virus
ER Allen, SA Krumm, J Raghwani, S Halldorsson, A Elliott, VA Graham, ...
Cell reports 25 (13), 3750-3758. e4, 2018
292018
Plasmodium falciparum antigenic variation: relationships between widespread endothelial activation, parasite PfEMP1 expression and severe malaria
AI Abdi, G Fegan, M Muthui, E Kiragu, JN Musyoki, M Opiyo, K Marsh, ...
BMC infectious diseases 14 (1), 1-11, 2014
272014
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20